$19.16
00.00%
Last update: Sep 5, 8:00 PM
15 minutes delayed
Comments
Loading...
ETF Managers Trust ETFMG Treatments Testing & Advancements ETF
GERMARCA
Sector
Healthcare
Region
US
AUM
9.40M
Fund Score
ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (ARCA:GERM) Quotes, Forecast and News Summary
ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (ARCA: GERM) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | - |
| AUM | 9.40M |
| Dividend | $0.24 |
| Ex-Div Date | Jun 27, 2024 |
| Volume | - |
| Market Cap | $27.77B |
| Mgmt Fee | 0.68% |
| P/E Ratio | 20.36 |
| Prev. Close | $19.16 |
| Low | - |
| 52 Wk Low | - |
| Shares Out | 650.00K |
| Yield | 1.27% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 1.08K |
| Beta | 0.91 |
| Avg. Expense Ratio | 0.68% |
| P/B Ratio | 1.72 |
Recent News
FAQ
How do I buy ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (GERM) stock?
You can purchase shares of ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (ARCA:GERM) through any online brokerage.
Who are ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (GERM) competitors?
There are no as such competitors for ETF Managers Trust ETFMG Treatments Testing & Advancements ETF.
What is the forecast, or price target, for ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (GERM) stock?
There is no analysis for ETF Managers Trust ETFMG Treatments Testing & Advancements ETF to provide a consensus price target.
What is the current price for ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (GERM)?
The stock price for ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (ARCA: GERM) is $19.1577 last updated September 5, 2024 at 8:00 PM EDT.
Does ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (GERM) pay a dividend?
There are no upcoming dividends for ETF Managers Trust ETFMG Treatments Testing & Advancements ETF.
When is ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (ARCA:GERM) reporting earnings?
ETF Managers Trust ETFMG Treatments Testing & Advancements ETF does not have any upcoming earnings scheduled.
Is ETF Managers Trust ETFMG Treatments Testing & Advancements ETF (GERM) going to split?
There is no upcoming split for ETF Managers Trust ETFMG Treatments Testing & Advancements ETF.
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Jun 17, 2020 |
| Managers | Qiao Duan Charles A. Ragauss |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
Under normal circumstances, the Fund invests at least 80 percent of its net assets (plus borrowings for investment purposes) in U.S.-listed equity securities or American Depositary Receipts (ADRs) of Treatments, Testing and Advancements Companies (as defined below). In general, the Index seeks to be comprised of companies: i) performing advancements in research, development, and commercialization of treatments or vaccines for infectious diseases, or ii) engaged in the advancement of research, development, manufacturing, and provision of biological tests for patients.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| ALNY | Alnylam Pharmaceutical... | 9.66% |
| LH | Laboratory Corporation... | 6.60% |
| DGX | Quest Diagnostics Inc | 6.06% |
| FF | Biontech Se | 5.14% |
| BIO | Bio-Rad Laboratories-A... | 4.74% |
| MRNA | Moderna therapeutics | 4.68% |
| PCVX | Vaxcyte Inc | 4.41% |
| SH | Zai Lab Ltd-adr | 4.06% |
| IMCR | Immunocore Holdings Lt... | 3.77% |
| QDEL | Quidel Corp | 3.74% |